INFUSION Magazine

REGULATORY/LEGISLATIVE ISSUES

Alborghetti M. Medical waste: No "throw-away" issue. 1999;5(12):20-5.

Antone TM, Sylvia LM. Operation Restore Trust and Wedge unit investigations: A survival guide. 1997;4(3):14-22.

Appel HM. Moving toward PPS: The shift is upon us. 1998;5(2):35-37.

Baker Kenneth R. Sterile compounding oversight: Legal challenges, practice considerations.200713(2);20-3.

Barrell JM. Infusion providers wake up to the future. 1998;4(10):37-40.

Barrell JM. Corporate compliance starts with commitment. 1998;4(10):51-54.

Barrell JM. Grassroots advocacy: Even in Washington, it's the people that matter. 2000;6(4):11-5.

Barrell JM. Legislative and regulatory review. 2002;8(3):22-9.

Borfitz D. Home health care agency quagmire offers lessons for home infusion. 1999;5(10):35-37.

Carder EB. Enforcement activity in home I.V. therapy. 1995;1(5):28-32.

Counce J. HIPAA security rule imminent, providers best prepare. 2004;10(4):28-32.

Counce J. Medicaid simplified: How standardization could streamline home infusion claims to Medicaid. 2004;10(5):28-31.

Counce JB. Home IGIV under Medicare: Patients still waiting for meaningful coverage. 2005:11(2):12-20.

Counce JB. Medicare part D: The education begins. 2005. 11(3):18-21.

Counce JB. Average sales price and home infusion: What does the future hold? 2005. 11(3):26-31.

Counce: JB. Providers meet policymakers: NHIA’s first-ever legislative conference brings Medicare Part D concerns to forefront.  11(6):21-5.

Counce J. The NHIA 2nd annual legislative conference: Read all about it! 2006. 12(5):12-17.

Counce J. Bringing it home: Pennsylvania provider hosts facility tours for legislators. 2006.12(5):19-21.

Counce J. The NHIA 3rd annual legislative conference: The push for meaningful Medicare coverage continues.2007:13(5);17-21.

Counce J. Taking it to the streets: What you can—and should--do at home to push for meaningful Medicare coverage of home infusion therapies.2007:13(5);25-7.

Counce J. Every voice makes a difference: Coordinated member outreach helps move NHIA’s legislative efforts forward. 2008.14(6):24-9.

Counce J. The 2009 NHIA Legislative hill day: Historic opportunity for infusion professionals in Washington, D.C. 2008.14(6):29-31.

Counce J and Jurich S. Alternate-site infusion provider roundtable: A discussion of urgency—Why active grassroots is key to achieving meaningful Medicare coverage for home infusion therapy, 2008.14(6):33-7.

Counce J. Every Voice Makes a Difference—A 2009 NHIA Legislative Hill Day Retrospective. 2009:15(3);23-8.

Dasher T. Heads up for the balanced budget act of 1997. 1998;4(4):45-46.

Dentino-Olson P. Getting it right the first time: Understanding the structure of Medicare Part B reimbursement for home infusion therapy.2008:14(2);24-7.

Dobson A, Lamphere J, Koenig L, and Babcock J. Impact of proposed AWPs on the provision of home care drug therapies to medicare and medicaid patients. 2001;7(2):22-7.

Flores KA. Compliance: A part of your quality improvement process. 2000;6(6):27-30.

Franklin DM. Regulatory compliance: Self-preservation skills in a perilous environment. 2001;7(5):34-8.

Franklin DM. Compliance defined. 2003;9(2):42-6.

Franklin DM. CMS makes major changes to the Medicare appeals process. 11(4):47-50.

Franklin DM. Medicare Part D: The first year in review.2007:13(1);40-3.

Franklin DM. Revolution!2007:13(4);39-24.

Franklin DM. Post-payment audit strategies.2007:13(5);40-2.

Franklin DF. Pharmacy and Medicare Part B: A brief overview.2007:13(6);41-4.

Franklin DM. Competitive Bidding: A Stratagem of Fools. 2008;14(4):43-6.

Franklin D. Guardians of care: Why the Medicare home infusion coverage act should be passed. 2008.14(6): 48-51.

Getson L. United we stand: New standards for ethical practice will codify NHIA member commitment to integrity and unite the alternate-site infusion field. 2010; 16(6):25-7.

Grady D. NHIA’s Hill Day 2009: A Chance to Learn, a Chance to Educate. 2009:15(1);40-1.

Ginsburg PB. Competition in health care: Its evolution over the past decade. 2006.12(6):28-37.

Hedlund CT. Stark II: More on HCFA's proposed regulation. 1998;4(7):51-55.

Hedlund CT. Stark II: How HCFA's proposed regulations affect infusion providers. 1998;4(6):42-45

Hedlund CT. Get ready for Stark II. 1994;1(2):15-18.

Kaplan LK. Captive referrals: The legal implications. 1996;2(10):27.

Kaplan LK. Collective negotiation: An idea whose time has come. 1999;5(11):10-13.

Kaplan LK. Home infusion coding and claiming: Big changes are in the works. 2000;7(1):40-1.

Kaplan LK. HIPAA, HIEC, and home infusion claiming and coding: Questions and answers. 2000;7(1):42-5.

Kaplan LK. How to use the new HCPCS home infusion codes. 2002;8(2):24-8.

Kaplan LK. PBMs: A review of litigation and legislation. 2003;9(6):14-9.

Kramer N and Counce J. The significant seven: Things you might not know about employee and environmental health and safety regulations—but should. 2011; 17(4):21-27.

Magnuson J. New Congress, New Opportunities. 200; 16(6):11-14.

Magnuson J. NHIA Advocacy Team, Members Move Legislative Agenda Forward. 2008.14(6): 17-21.

Magnuson J. Sustaining Our Momentum in the Grassroots. 2009:15(3);29-31.

Magnuson J. Congressional Committees—A Critical Key to Successful Grassroots Activity. 2009:15(1);12-3.

Magnson J. Fostering Teamwork! NHIA’s advocacy message is getting out—but your help is still urgently needed.2009:15(4);18-20.

Magnuson J. Gearing up for essential delivery system reform—Now is the time to further grow our grassroots capacity. 15(5):13-17.

Magnuson J. Pursuing a Demonstrations Project—Amid a Variety of Paths. 2010; 16(5):16-19.

Magnuson J. From advocacy to advocate.  2011; 17(4):8-10.

Magnuson J. Health Care Reform, Repeal, and the Importance of Remaining Engaged. 2011; 17(1):17-19.

Magnuson J. Putting a face to the lack of meaningful Medicare home infusion coverage. 2011; 17(5):8-10.

Magnuson J. Accountable care organizations take shape. 2011;17(6):6-8.

Maranville C. Home infusion therapy under Medicare Par D: One provider’s experience.2007:13(2);35-9.

Masoorli S. Central vascular access devices in home care: Legal issues. 2000;6(10):31-5.

NHIA and NAIT join forces to fight deep enteral formula cuts. 1998;5(3):32-39.

NHIA.  Consolidating home infusion therapy coverage under Medicare Part B could save the Medicare program millions of dollars in 2006. 11(6):37-8.

NCPA. APHA, NACDS. Implementing effective change in meeting the demands of community pharmacy practice in the United States: A white paper. 1999;6(2):43-8.

Rappa E and Ness S. Balancing medication access and risk: What the FDA's REMS programs mean for infusion pharmacy. 2011; 17(6):16-23.

Richardson RJ. NHIA raises concerns on proposed Medicare policies for home parenteral nutrition. 1995;1(11):28-36.

Rodman B. Reimbursement Issues on the Horizon. 2008;14(5):40-2.

Rodman B and Counce J. Trouble getting home: Study finds Medicare Part D hampers access for home infusion therapy access for dual-eligible patients.2007:13(1);34-7.

Rollins G. Prompt payment laws: A new weapon in the managed care struggle. 2000;6(9):21-4.

Rollins G. The Medicaid AWP challenge: Providers respond. 2000;7(1):36-.9

Rollins G. Spotlight on HIPAA privacy and patient rights. 2003;9(2):14-9.

Salvatore T, Baxter T. Beyond compliance: Building an ethical framework for your organization. 1998;5(2):39-42.

Shenton W. HIPAA: Is it overhyped. 2001;7(3):18-25.

Smith DE. In the Driver's Seat. 2000;6(9):35-8.

Stribling C. Managing risk with corporate compliance programs.200713(2);25-8.

Tallon R. DMERC policy perspectives: Food for thought. 1994;1(1):20-23.

Tallon RW. IDPN: The controversy continues. 1994;1(3):22-26.

Vance S. Communicating with congress. 2001;7(2):28-30.

Warren MW, Andrusko-Furphy KT. OASIS and home infusion: Measurement or mirage? 1999;5(8):38-43.

Weber P. Providers and payers will soon be speaking the same language: Electronic claims under HIPAA. 2003;9(4):16-20.